<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mutations in the LMNA gene, encoding the nuclear envelope protein lamin A/C, are responsible for a number of distinct disease entities including Dunnigan-type familial partial <z:hpo ids='HP_0009125'>lipodystrophy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Dunningan-type <z:hpo ids='HP_0009125'>lipodystrophy</z:hpo> is characterized by <z:mp ids='MP_0000012'>loss of subcutaneous adipose tissue</z:mp>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and shares many of the features of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, several genome-wide linkage scans for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> have found evidence of linkage at chromosome 1q21.2, the region that harbors the LMNA gene </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, LMNA is a biological and positional candidate for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> susceptibility </plain></SENT>
<SENT sid="4" pm="."><plain>Previous studies have reported association between a common LMNA variant (1908C&gt;T; rs4641) and adverse metabolic traits in ethnically diverse populations from Asia and North America </plain></SENT>
<SENT sid="5" pm="."><plain>In the present study, we characterized the common variation across the LMNA gene (including rs4641) and tested for association with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in two large case-control studies (n = 2,052) and with features of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in a separate cohort study (n = 1,572) </plain></SENT>
<SENT sid="6" pm="."><plain>Despite our study being sufficiently powered to detect effects similar and even smaller in magnitude than those previously reported, none of the LMNA single nucleotide polymorphisms were statistically significantly associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, it appears unlikely that variation at LMNA substantially increases the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or related traits in U.K </plain></SENT>
<SENT sid="8" pm="."><plain>Europids </plain></SENT>
</text></document>